Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Universal Assay Platform Allows Rapid Blood Grouping

By HospiMedica International staff writers
Posted on 28 Mar 2017
A new study describes how a paper-based point-of-care assay could provide fast and reliable blood group testing at the patient’s bedside.

Developed by researchers at Third Military Medical University, the paper-based assay uses immobilized antibodies and bromocresol green dye for rapid and reliable blood grouping, where dye-assisted color changes corresponding to distinct blood components provide a visual readout for each antigen (A, B, and Rhesus). The researchers also developed a machine-learning method that can classify spectral plots corresponding to the color changes, which enables reproducible automatic grouping.

The assay identifies ABO antigens and five major Rhesus antigens within 30 seconds using small volumes (100 μl) of whole blood, thus allowing simultaneous forward and reverse ABO blood grouping within two minutes through on-chip plasma separation, and all without centrifugation. When tested with optimized operating parameters, the dye-assisted paper assay exhibited comparable accuracy and reproducibility to the classical gel-card assays in grouping 3,550 human blood samples, with more than 99.9% accuracy. The study was published on March 15, 2017, in Science Translational Medicine.

“Fast and simultaneous forward and reverse blood grouping has long remained elusive. Forward blood grouping detects antigens on red blood cells, whereas reverse grouping identifies specific antibodies present in plasma,” concluded lead author Hong Zhang, PhD, and colleagues. “The paper strip could be used in war zones or remote areas where there are no labs to test patients’ blood types. O blood is currently used in these contexts, but supplies are limited.”

There are four major blood groups determined by the presence or absence of two antigens (A and B) on the surface of red blood cells (RBCs). Group A has only the A antigen on RBCs, and B antibody in the plasma; Group B has only the B antigen on RBCs, and A antibody in the plasma; Group AB has both A and B antigens on RBCs, but neither A nor B antibody in the plasma; and Group O has neither A nor B antigens on RBCs, but both A and B antibody in the plasma. In addition to the A and B antigens, there is a third antigen called the rhesus (Rh) factor, which can be either present (+) or absent (–). The universal red cell donor has Type O– blood type, and the universal plasma donor has Type AB+ blood type.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Vital Signs Monitor
iM3s
New
Suction Electrode System
Strässle
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The stretchy hydrogel and a vial of liquid polymer (Photo courtesy of WPI)

New Class of Bioadhesives to Connect Human Tissues to Long-Term Medical Implants

Medical devices and human tissues differ significantly in their composition. While medical devices are primarily constructed from hard materials like metal and plastic, human tissue is soft and moist.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.